Gilead Sciences: Lessons learned from the Covid-19 frontline
Gilead Sciences was able to use its library of antivirals, which the company routinely scans for different viruses, to gain a head start on tackling the Covid-19 virus.
Virologists have argued for many years that the greatest threat to human health would come from a virus which doesn’t yet exist in humans. As we continue to fight Covid-19 pandemic, few of us would question that claim.
